IDEAYA Biosciences, Inc.IDYANASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank88
5Y CAGR-21.6%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-21.6%/yr
Long-term compound
Percentile
P88
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 71.28% |
| 2024 | -114.87% |
| 2023 | -32.18% |
| 2022 | -56.29% |
| 2021 | -200.57% |
| 2020 | 241.08% |
| 2019 | -42.34% |
| 2018 | -125.95% |
| 2017 | 0.00% |